Opioid receptors: from binding sites to visible molecules in vivo.

Neuropharmacology
Brigitte L Kieffer, Christopher J Evans

Abstract

Opioid drugs such as heroin interact directly with opioid receptors whilst other addictive drugs, including marijuana, alcohol and nicotine indirectly activate endogenous opioid systems to contribute to their rewarding properties. The opioid system therefore plays a key role in addiction neurobiology and continues to be a primary focus for NIDA-supported research. Opioid receptors and their peptide ligands, the endorphins and enkephalins, form an extensive heterogeneous network throughout the central and peripheral nervous system. In addition to reward, opioid drugs regulate many functions such that opioid receptors are targets of choice in several physiological, neurological and psychiatric disorders. Because of the multiplicity and diversity of ligands and receptors, opioid receptors have served as an optimal model for G protein coupled receptor (GPCR) research. The isolation of opioid receptor genes opened the way to molecular manipulations of the receptors, both in artificial systems and in vivo, contributing to our current understanding of the diversity of opioid receptor biology at the behavioral, cellular and molecular levels. This review will briefly summarize some aspects of current knowledge that has accumulated since...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B L KiefferC G Hirth
Dec 28, 1992·Science·C J EvansR H Edwards
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R SpanagelT S Shippenberg
Jul 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·E J SimonI Edelman
Mar 9, 1973·Science·C B Pert, S H Snyder
Jan 1, 1984·Annual Review of Neuroscience·H AkilJ M Walker
Apr 26, 1996·The Journal of Biological Chemistry·K BefortB L Kieffer
Aug 9, 1996·The Journal of Biological Chemistry·D E KeithM von Zastrow
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·P A ZakiF Porreca
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·C SterniniN C Brecha
Oct 6, 1998·Annual Review of Biochemistry·R Y Tsien
Jan 3, 2001·European Journal of Pharmacology·K S LaForgeM J Kreek
Dec 12, 2001·Neuroscience·E J Van Bockstaele, K G Commons
Jan 12, 2002·Current Opinion in Pharmacology·Brandon A R LevacSusan R George
May 17, 2002·Progress in Neurobiology·Brigitte L Kieffer, Claire Gavériaux-Ruff
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Kristen L PierceRobert J Lefkowitz
Jul 9, 2003·Nature Structural Biology·Fabien M DécaillotBrigitte L Kieffer
Aug 5, 2003·Nature Reviews. Genetics·Anna-Katerina HadjantonakisVirginia E Papaioannou
Aug 27, 2003·The Journal of Biological Chemistry·Michael Tanowitz, Mark von Zastrow
Nov 11, 2003·Trends in Pharmacological Sciences·Edwin H JacobsAnton N M Schoffelmeer
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Christopher M TanLee E Limbird
Jun 15, 2004·Current Opinion in Neurobiology·Candice ContetKatia Befort
Jun 26, 2004·Science·Anna MolesFrancesca R D'Amato
Oct 7, 2004·Neuropharmacology·Christopher J Evans
Mar 2, 2005·European Journal of Pain : EJP·Anthony H Dickenson, Rie Suzuki
Jun 1, 2005·Trends in Pharmacological Sciences·Kazutaka IkedaIchiro Sora
Sep 27, 2005·Pharmacology & Therapeutics·Charles P O'Brien, Eliot L Gardner
Oct 28, 2005·Nature Neuroscience·Eric J Nestler
Dec 14, 2005·Pharmacogenetics and Genomics·Peter Mayer, Volker Höllt
Jan 31, 2006·Trends in Neurosciences·Véronique BernardBertrand Bloch
Feb 21, 2006·The European Journal of Neuroscience·Xavier NadalRafael Maldonado
Jun 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Grégory ScherrerBrigitte L Kieffer
Jul 1, 2006·Molecular Interventions·Emily M Jutkiewicz
Oct 31, 2006·Trends in Molecular Medicine·Ruben D Baler, Nora D Volkow

❮ Previous
Next ❯

Citations

Jan 19, 2012·Cellular and Molecular Neurobiology·Xavier RezaïDominique Massotte
Apr 23, 2013·Trends in Pharmacological Sciences·Christoph Stein, Sarah Küchler
Apr 12, 2012·Expert Reviews in Molecular Medicine·Cristina M CostantinoLakshmi A Devi
Feb 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William E CopelandChristina S Barr
Jul 11, 2012·Endocrinology·Roxanne DutiaSharon L Wardlaw
Feb 6, 2013·PloS One·Barbara ZavanPaolo Pinton
Aug 31, 2013·Life Sciences·Celso M Queiroz-JuniorCinthia M F Pacheco
Jun 11, 2011·Current Opinion in Anaesthesiology·Banafscheh Rachinger-AdamShahnaz C Azad
Jun 10, 2011·Expert Opinion on Investigational Drugs·Thomas HillemacherHelge Frieling
Feb 3, 2016·Clinics in Sports Medicine·Matthew J Matava
Nov 27, 2010·Neuropharmacology·Maria Hadjiconstantinou, Norton H Neff
May 29, 2012·Pain Practice : the Official Journal of World Institute of Pain·George MiljanichMichael Saulino
Jul 25, 2012·Annals of the New York Academy of Sciences·Jürgen Kraus
Jun 8, 2012·Annals of the New York Academy of Sciences·D HackelH L Rittner
Jun 14, 2014·British Journal of Pharmacology·A M W TaylorC J Evans
Dec 21, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ulla E Petäjä-Repo, Jarkko J Lackman
Jul 6, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mariana SpeteaHelmut Schmidhammer
Mar 26, 2013·European Journal of Pharmacology·Xavier NadalRafael Maldonado
Jan 23, 2015·Frontiers in Pharmacology·Rhian A Ceredig, Dominique Massotte
May 24, 2014·Biology of Reproduction·Yongjie ChenHaibin Wang
Mar 13, 2017·Psychopharmacology·Haval Norman, Manoranjan S D'Souza
Nov 11, 2017·British Journal of Pharmacology·Rafael MaldonadoDavid Cabañero
Jun 1, 2018·Annual Review of Neuroscience·Gregory CorderGrégory Scherrer
Jul 28, 2018·Journal of Neuroscience Research·Pierre-Eric LutzRaffaella Calati
Sep 4, 2018·Neuropsychopharmacology Reports·Winston W Shen
Mar 12, 2019·Medicine, Science, and the Law·Chiara ChindemiDomenico De Leo
Nov 23, 2017·Development and Psychopathology·Sarah R MooreMichael S Kobor
Jan 20, 2012·Molecular Pharmacology·Christine BörnerJürgen Kraus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved